Louis W. Sullivan, Director at Emergent BioSolutions Inc. (EBS), sold 47,631 shares at $39.00 ($1.9M) on 2016-05-12, disclosed to the SEC on 2016-05-16.
Seasonal sale ($1.9M) by Director — this insider has traded EBS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.00 | 300 | $12K | 0.6% |
| 2 | $39.00 | 4,131 | $161K | 8.6% |
| 3 | $39.19 | 21,600 | $847K | 45.3% |
| 4 | $39.28 | 21,600 | $848K | 45.4% |
| Total | $39.21 avg | 47,631 | $1.9M | 100% |
| Filing → |
| UTHR | SELL | 2024-05-06 | $2.7M | — | Filing → |
| UTHR | SELL | 2023-03-02 | $172K | — | Filing → |
| UTHR | SELL | 2023-02-02 | $183K | — | Filing → |